Koers Kamada Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0010941198
Farmaceutische producten
Omzet 2024 * | 573 mln. 153 mln. 57,34 mld. 144 mln. | Omzet 2025 * | 706 mln. 189 mln. 70,6 mld. 177 mln. | Marktkapitalisatie | 1,14 mld. 305 mln. 114 mld. 286 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 46 mln. 12,31 mln. 4,6 mld. 11,52 mln. | Nettowinst (verlies) 2025 * | 84 mln. 22,47 mln. 8,4 mld. 21,04 mln. | EV/omzet 2024 * | 1,99 x |
Nettoliquiditeiten 2024 * | - 0 0 0 | Nettoliquiditeiten 2025 * | - 0 0 0 | EV/omzet 2025 * | 1,62 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,25% |
Recentste transcriptie over Kamada Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09-12-13 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24-12-19 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,45% | 87,17 mld. | |
+2,76% | 40,1 mld. | |
-17,33% | 31,38 mld. | |
+57,86% | 25,12 mld. | |
-16,29% | 15,59 mld. | |
-9,12% | 12 mld. | |
-42,56% | 11,8 mld. | |
-17,88% | 11,8 mld. | |
+6,89% | 8,81 mld. |